Market by Type, Form, Livestock, Application, End-user, and Country | Forecast 2021-2028
As
per Triton’s report, the eubiotics market in Europe is assessed to witness
growth at a compound annual growth rate of 7.34% during the estimated phase
from 2021 to 2028.
Report scope can be customized per your requirements. Request For Customization
The
countries studied in this market comprise:
• The United Kingdom
• Spain
• Germany
• Italy
• France
• Russia
• Rest of Europe
In
the region, concerns pertaining to sustainability are evaluated to drive the
meat industry over the next few years, encouraging production with few animals.
Besides, some of the nations have implemented strict animal welfare
regulations, which adds to the growth of the studied market. Additionally, the
rising animal disease outbreaks have influenced the demand for eubiotics across
the region. Furthermore, the prohibition of antibiotics in animal feed
significantly supports the gradual demand for eubiotics, thereby augmenting the
development of the eubiotics market across European countries.
In
the United Kingdom, overall meat consumption has surged over the past few
years. In this regard, producers in the poultry sector have reduced the cost of
production. Furthermore, the outbreak of animal diseases, such as mad cow
disease and foot-and-mouth disease, significantly impacts livestock. The
emergence of such diseases has created awareness relating to animal health and
safety. Therefore, as mentioned above, all these factors are motivating the
development of the eubiotics market across the country.
BASF
SE offers petrochemicals, intermediates, performance materials, and other
products. Its wide product line includes Amasil, a formic acid supporting key
animal performance via optimal feed hygiene. It is an effective manner of
acidifying feed, eradicating salmonella, and preventing molds. The company
serves clients across consumer goods, agriculture, health and nutrition, and
other industries. With operations across various regions, BASF is headquartered
in Germany.
1. EUROPE
EUBIOTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON EUBIOTICS MARKET
2.2. KEY
INSIGHTS
2.2.1. EUBIOTICS
AS AN ALTERNATIVE TO ANTIBIOTICS
2.2.2. APPLICATIONS
OF EUBIOTICS IN CALVES' GUT HEALTH
2.2.3. DEVELOPING
FOOD ADDITIVE PLATFORM BASED ON GRAINS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. CONTRACTS
& AGREEMENTS
2.6.3. PRODUCT
LAUNCHES
2.6.4. EXPANSIONS
2.7. MARKET
DRIVERS
2.7.1. RISING
MEAT CONSUMPTION
2.7.2. GROWING
AWARENESS AND CONCERNS REGARDING ANIMAL HEALTH
2.7.3. INCREASING
DEMAND FOR MANUFACTURED FEEDS
2.8. MARKET
CHALLENGES
2.8.1. UNAWARENESS
ABOUT EUBIOTICS
2.9. MARKET
OPPORTUNITIES
2.9.1. GOVERNMENT
SUPPORT FOR EUBIOTICS USE
2.9.2. PROBIOTICS
SPRAY COATINGS
2.9.3. ESSENTIAL
OILS FOR NECROTIC ENTERITIS
3. EUROPE
EUBIOTICS MARKET OUTLOOK - BY TYPE
3.1. PROBIOTICS
3.2. ORGANIC
ACID
3.3. PREBIOTICS
3.4. ESSENTIAL
OILS
4. EUROPE
EUBIOTICS MARKET OUTLOOK - BY FORM
4.1. DRY
4.2. LIQUID
5. EUROPE
EUBIOTICS MARKET OUTLOOK - BY LIVESTOCK
5.1. SWINE
5.2. POULTRY
5.3. RUMINANTS
5.4. AQUACULTURE
5.5. OTHER
LIVESTOCK
6. EUROPE
EUBIOTICS MARKET OUTLOOK - BY APPLICATION
6.1. GUT
HEALTH
6.2. IMMUNITY
6.3. YIELD
MANAGEMENT
6.4. OTHER
APPLICATIONS
7. EUROPE
EUBIOTICS MARKET OUTLOOK - BY END-USER
7.1. ANIMALS
7.2. HUMANS
8. EUROPE
EUBIOTICS MARKET – REGIONAL OUTLOOK
8.1. UNITED
KINGDOM
8.2. GERMANY
8.3. FRANCE
8.4. SPAIN
8.5. ITALY
8.6. RUSSIA
8.7. REST
OF EUROPE
9. COMPETITIVE
LANDSCAPE
9.1. ANPARIO
PLC
9.2. ARCHER
DANIELS MIDLAND
9.3. BASF
SE
9.4. BEHN
MEYER GROUP
9.5. BENEO
GMBH
9.6. CARGILL
INC
9.7. CHR
HANSEN HOLDING AS
9.8. DUPONT
DE NEMOURS INC
9.9. KEMIN
INDUSTRIES INC
9.10. KONINKLIJKE
DSM NV
9.11. LALLEMAND
INC
9.12. LESAFFRE
9.13. NEOSPARK
DRUGS AND CHEMICALS PRIVATE LIMITED
9.14. NOVUS
INTERNATIONAL INC
9.15. YARA
INTERNATIONAL ASA
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE EUBIOTICS
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: COUNTRIES WITH
THE HIGHEST ANNUAL MEAT CONSUMPTION
TABLE 4: MAJOR LIVESTOCK
DISEASES IN THE WORLD
TABLE 5: EUROPE
EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: EUROPE
EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)
TABLE 7: EUROPE
EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE
EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE
EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE
EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: EUROPE EUBIOTICS MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE 3: EUROPE EUBIOTICS MARKET, BY PROBIOTICS, 2021-2028 (IN $
MILLION)
FIGURE 4: EUROPE EUBIOTICS MARKET, BY ORGANIC ACID, 2021-2028 (IN $
MILLION)
FIGURE 5: EUROPE EUBIOTICS MARKET, BY PREBIOTICS, 2021-2028 (IN $
MILLION)
FIGURE 6: EUROPE EUBIOTICS MARKET, BY ESSENTIAL OILS, 2021-2028 (IN $
MILLION)
FIGURE 7: EUROPE EUBIOTICS MARKET, BY FORM, 2020 & 2028 (IN %)
FIGURE 8: EUROPE EUBIOTICS MARKET, BY DRY, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE EUBIOTICS MARKET, BY LIQUID, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE EUBIOTICS MARKET, BY LIVESTOCK, 2020 & 2028 (IN %)
FIGURE 11: EUROPE EUBIOTICS MARKET, BY SWINE, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE EUBIOTICS MARKET, BY POULTRY, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE EUBIOTICS MARKET, BY RUMINANTS, 2021-2028 (IN $
MILLION)
FIGURE 14: EUROPE EUBIOTICS MARKET, BY AQUACULTURE, 2021-2028 (IN $
MILLION)
FIGURE 15: EUROPE EUBIOTICS MARKET, BY OTHER LIVESTOCK, 2021-2028 (IN $
MILLION)
FIGURE 16: EUROPE EUBIOTICS MARKET, BY APPLICATION, 2020 & 2028 (IN
%)
FIGURE 17: EUROPE EUBIOTICS MARKET, BY GUT HEALTH, 2021-2028 (IN $
MILLION)
FIGURE 18: EUROPE EUBIOTICS MARKET, BY IMMUNITY, 2021-2028 (IN $ MILLION)
FIGURE 19: EUROPE EUBIOTICS MARKET, BY YIELD MANAGEMENT, 2021-2028 (IN $
MILLION)
FIGURE 20: EUROPE EUBIOTICS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN
$ MILLION)
FIGURE 21: EUROPE EUBIOTICS MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE 22: EUROPE EUBIOTICS MARKET, BY ANIMALS, 2021-2028 (IN $ MILLION)
FIGURE 23: EUROPE EUBIOTICS MARKET, BY HUMANS, 2021-2028 (IN $ MILLION)
FIGURE 24: EUROPE EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN
%)
FIGURE 25: UNITED KINGDOM EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: GERMANY EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: FRANCE EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: SPAIN EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: ITALY EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: RUSSIA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: REST OF EUROPE EUBIOTICS MARKET 2021-2028 (IN $ MILLION)